WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...
ST. PAUL, Minn. -- St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the AMPLATZER™ ...
For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...
MINNEAPOLIS--(BUSINESS WIRE)--AGA Medical Corporation has received European CE Mark approval for its AMPLATZER ® vascular plug, AVP 4. The device, which is indicated for arterial and venous ...
Procedures involving use of a collagen plug-based vascular closure device rarely led to the onset of critical limb ischemia, according to results of a new study. Researchers retrospectively ...
SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) ...
Please provide your email address to receive an email when new articles are posted on . Covidien plc has acquired Reverse Medical Corporation, a privately held medical device company focused on ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results